FBL-MTX

DRUG2 trials

Sponsors

SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd

Conditions

Rheumatoid Arthritis

Phase 1

Investigate the Safety, Tolerability and Pharmacokinetics of FBL-MTX

CompletedNCT05117593

SOLFARCOS - Pharmaceutical and Cosmetic Solutions LtdRheumatoid Arthritis

Start: 2021-06-28End: 2021-10-19Updated: 2021-11-22

Phase 2

Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis

Active, not recruitingNCT06565273

SOLFARCOS - Pharmaceutical and Cosmetic Solutions LtdRheumatoid Arthritis

Start: 2024-07-24End: 2026-06-30Target: 40Updated: 2026-06-11